December 4, 2022

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that early initiation of tumor necrosis factor (TNF) inhibitors was associated with higher risk of heart disease in patients diagnosed with ankylosing spondylitis. Researchers caution that confounding by indication may have influenced the results.


Leave a Reply

Your email address will not be published. Required fields are marked *